about
In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine.DNA-based influenza vaccines: evaluating their potential to provide universal protection.Influenza A vaccines using linear expression cassettes delivered via electroporation afford full protection against challenge in a mouse model.Altered response hierarchy and increased T-cell breadth upon HIV-1 conserved element DNA vaccination in macaques.Optimization of electroporation-enhanced intradermal delivery of DNA vaccine using a minimally invasive surface device.A multi-head intradermal electroporation device allows for tailored and increased dose DNA vaccine delivery to the skinTransient receptor potential-like channels are essential for calcium signaling and fluid transport in a Drosophila epithelium.HIV-1 p24(gag) derived conserved element DNA vaccine increases the breadth of immune response in mice.Direct transfection of dendritic cells in the epidermis after plasmid delivery enhanced by surface electroporation.Comparison of immune responses generated by optimized DNA vaccination against SIV antigens in mice and macaquesImmunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responses.HIV-1 Env DNA vaccine plus protein boost delivered by EP expands B- and T-cell responses and neutralizing phenotype in vivoDNA vaccination strategy targets epidermal dendritic cells, initiating their migration and induction of a host immune response.Elucidating the Kinetics of Expression and Immune Cell Infiltration Resulting from Plasmid Gene Delivery Enhanced by Surface Dermal Electroporation.Enhanced Delivery and Potency of Self-Amplifying mRNA Vaccines by Electroporation in SituEnhanced Efficacy of a Codon-Optimized DNA Vaccine Encoding the Glycoprotein Precursor Gene of Lassa Virus in a Guinea Pig Disease Model When Delivered by Dermal Electroporation.Protection against dengue disease by synthetic nucleic acid antibody prophylaxis/immunotherapy.Optimized in vivo transfer of small interfering RNA targeting dermal tissue using in vivo surface electroporation.Role of cyclic GMP in gene regulation.Intradermal DNA vaccination enhanced by low-current electroporation improves antigen expression and induces robust cellular and humoral immune responses.DNA and virus particle vaccination protects against acquisition and confers control of viremia upon heterologous simian immunodeficiency virus challengeThe p40 subunit of interleukin (IL)-12 promotes stabilization and export of the p35 subunit: implications for improved IL-12 cytokine production.IL-12 DNA as molecular vaccine adjuvant increases the cytotoxic T cell responses and breadth of humoral immune responses in SIV DNA vaccinated macaquesSafety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b triAdjuvanted multi-epitope vaccines protect HLA-A*11:01 transgenic mice against Toxoplasma gondiiAugmentation of cellular and humoral immune responses to HPV16 and HPV18 E6 and E7 antigens by VGX-3100Electroporation mediated DNA vaccination directly to a mucosal surface results in improved immune responses.Comparison of intradermal and intramuscular delivery followed by in vivo electroporation of SIV Env DNA in macaques.Skin Transfection Patterns and Expression Kinetics of Electroporation-Enhanced Plasmid Delivery Using the CELLECTRA-3P, a Portable Next-Generation Dermal Electroporation DeviceCharacterization of guinea pig T cell responses elicited after EP-assisted delivery of DNA vaccines to the skin.Clinical development of intramuscular electroporation: providing a "boost" for DNA vaccines.Electroporation-enhanced delivery of nucleic acid vaccines.Development of an intradermal DNA vaccine delivery strategy to achieve single-dose immunity against respiratory syncytial virus.Nucleic acid-based vaccines targeting respiratory syncytial virus: delivering the goods.Guanosine 3',5'-cyclic monophosphate (cGMP)/cGMP-dependent protein kinase induce interleukin-6 transcription in osteoblasts.Enhanced Delivery of DNA or RNA Vaccines by Electroporation.Nitric oxide scavenging by the cobalamin precursor cobinamide.Two nitridergic peptides are encoded by the gene capability in Drosophila melanogaster.Interactions between epithelial nitric oxide signaling and phosphodiesterase activity in Drosophila.Ectopic expression of bovine type 5 phosphodiesterase confers a renal phenotype in Drosophila.
P50
Q27901935-B18AC13B-6651-4549-ACB2-E8CA60F95AC0Q30394264-D6A524E9-E842-4610-AD37-12EC246E49D6Q30414135-925E291A-AC86-4CEB-B590-A6FCC8121BAFQ31148797-20773595-502B-4C3B-8EDD-66E3FF46AC88Q33586294-816EEAD9-1CE8-4BC2-B096-D72216EA319BQ33723334-5690E5C1-FD70-4DB7-8B92-1176C56808A7Q34572546-5EEFFFD1-DCD9-48C9-BF22-DBB44970C011Q34653619-59CF3EC4-FD20-4EF9-B8A8-8934D44A4A51Q34719492-C6DAA165-6889-48F7-A63B-A71380A338CCQ35046349-6514EDF9-4E2F-4EE6-B90B-0B2CB3282201Q35049821-8A5A00E4-F5A2-4571-8020-8195B0EF9544Q35082880-C739D6C3-C696-42B8-B708-4FD12C657A59Q35655963-B5C2C029-D07A-4FE1-B883-B548D6DF36DFQ35826661-A514900C-8F49-4E7A-AF30-3221E5E73656Q35826688-5267048C-3F30-4A14-A116-CFB9D5C4E89DQ35826698-40D227A0-96D3-45C5-B7D5-F0A90A041D58Q35898318-BD54C16B-B4F0-4043-8EC0-A994BDFF7734Q36053828-B4FDB211-51C4-48AB-BF51-0EA2F30D9904Q36071665-0865B1F7-C59A-43E3-9551-12A0EEEC9E8EQ36228884-E3FE354C-2E96-497C-B156-EE8C33640143Q36637349-D0D84887-9864-4EC0-B4D4-73F016128488Q36647429-8807BA17-E509-4C6F-A55B-C1F753883008Q36694836-EF40B8BF-C58B-4B44-84C5-6DD1F573EC3AQ36954152-ACCF1F32-E23B-4E91-A107-A27C23894C9AQ37277042-8D32B1B7-6018-4CE8-9D2C-AB9BDECA6ADBQ37489634-8AD39660-8EFA-4AB0-BC20-64B374206862Q37530445-55AB32F8-9C87-44E6-A675-5078A59F3E76Q37530466-2145D43F-8EB3-429C-BBF5-49AF0FAEDBEEQ37550619-30AA9A13-A76C-4B4A-B6BB-F735B9237729Q37573037-0453AA8C-7FFE-4F01-94C8-9DD48ACDF8DCQ38186674-E3699700-CC2A-4F1E-9F7B-CBE42E1293F9Q38285418-F21246EE-741D-48D6-85FB-C9F7CA9C148DQ38835118-C80344AB-FBE2-46F1-A55B-C66C33BCEDD0Q40053603-7AB57815-07B2-4FA6-AF4D-CF0DB8EA0E4BQ40162643-656F6767-9599-4C34-B69A-6D63AE843365Q40420214-7AE69CD1-3589-4A75-8ED1-EF47AFC21A1CQ40474770-967255D3-6E95-40ED-986F-52FBB6B4BB63Q42051764-CB7F2A1D-2655-4409-9336-391C3DD7E30FQ42444437-A49360B5-1211-4F7B-83CF-6DDF0732CCF3Q42453932-FAA827C6-4755-4D15-A383-E02ED3047086
P50
name
Kate E. Broderick
@en
type
label
Kate E. Broderick
@en
prefLabel
Kate E. Broderick
@en